Filing Details

Accession Number:
0001437749-12-012728
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-10 20:17:03
Reporting Period:
2012-12-06
Filing Date:
2012-12-10
Accepted Time:
2012-12-10 20:17:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389545 Novabay Pharmaceuticals Inc. NBY Pharmaceutical Preparations (2834) 680454536
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532040 W. David Stroman C/O Novabay Pharmaceuticals, Inc.
5980 Horton Street, Suite 550
Emeryville CA 94608
Svp, Ophthalmic Product Devt. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-06 10,000 $1.24 22,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to purchase Common Stock Acquisiton 2012-12-06 7,500 $0.01 7,500 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 2012-12-11 2013-12-11 No 4 P Direct
Footnotes
  1. At the public offering of the Company on December 6, 2012, Dr. Stroman purchased 10,000 shares of common stock with 7,500 warrants to purchase common stock.
  2. At the public offering of the Company on December 6, 2012, Dr. Stroman purchased 10,000 shares of common stock with 7,500 warrants to purchase common stock.